Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5944 Journals
5077 Congresses
11000+ Unique Records

Journal of Thoracic Disease


Title Abbreviation
J Thorac Dis
ISSN
2072-1439
Electronic ISSN
2077-6624
Readership
Cardiologists, Cardiovascular Surgeons, Clinical Researchers, Clinicians, Diagnosticians, Pulmonologists, Researchers
Scope
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624), founded in Dec 2009, is an international, peer-reviewed, open access journal covering the field of respiratory, lung, heart, esophageal and mediastinal diseases. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured. Published quarterly from December 2009 to December 2011 and bimonthly from January 2012 to December 2013, JTD now follows a monthly publication model. It has been indexed by Web of Science [Science Citation Index Expanded (SCIE)], PubMed/PubMed Central and Scopus. It received an impact factor of 2.3 for the year 2025. JTD is published by AME Publishing Company, with support from Wolters Kluwer (the journal content will be made available on Wolters Kluwer Health’s Lippincott and Ovid platforms).
Sponsoring Association(s)
Society for Translational Medicine (STM)
Publisher Name
AME Publishing Company
To see more details about Journal of Thoracic Disease, Subscribe Now!
Impact Factor JCR Categories/Rank Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader